Neuroacanthocytosis

doi:10.1017/CBO9780511544873.060

59 - Neuroacanthocytosis

from Part X - Other neurodegenerative diseases

Published online by Cambridge University Press: 04 August 2010

Anthony E. Lang and

M. Flint Beal: Affiliation:
Cornell University, New York
Anthony E. Lang: Affiliation:
University of Toronto
Albert C. Ludolph: Affiliation:
Universität Ulm, Germany
Alexander Storch: Affiliation:
Department of Neurology, Technical University of Dresden, Germany

Book contents

Get access

Summary

Acanthocytes (acanthos = thorny or spiny in Greek language) are mature red blood cells with multiple protrusions or spicules, often with terminal bulbs, which are irregular in shape, orientation, and distribution. Consequently, acanthocytosis is defined as an increased amount of such misshaped erythrocytes in peripheral blood. Acanthocytes should not be present in the peripheral blood, but in some general and neurological conditions, such as uremia, advanced hepatic disease, post-splenomegaly, advanced malnutrition or spur cell anemia, significant elevations of acanthocyte levels are reported (Brin, 1993; Stevenson & Hardie, 2001). The association of acanthocytosis with neurological syndromes is found in at least three hereditary neurological disorders that are generally referred to as neuroacanthocytosis syndromes (Table 59.1). The first recognized association was that of “malformation of the erythrocyte” in a sporadic case of progressive ataxia and pigmentary retinopathy by Bassen and Kornzweig in 1950 (Bassen & Kornzweig, 1950), but the underlying inherited metabolic abnormality of abetalipoproteinemia with secondary vitamin E deficiency was established years ago. Since then two other fairly distinct syndromes have emerged: the McLeod syndrome and autosomal recessive chorea-acanthocytosis.

Chorea-acanthocytosis (ChAc)

Chorea-acanthocytosis (ChAc; also referred to as Critchley–Levine syndrome; OMIM #200150) is a multisystem degenerative neurological disorder associated with acanthocytosis in the absence of any lipid abnormalities. ChAc was first described in the late 1960s by Estes and co-workers (1967) as well as by Critchley et al. (1968) and Levine et al. (1968) in two American kindreds with very similar features.

Type: Chapter
Information: Neurodegenerative Diseases
Neurobiology, Pathogenesis and Therapeutics
, pp. 871 - 879

DOI: https://doi.org/10.1017/CBO9780511544873.060 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Allen, F. H., Krabbe, S. M. R. & Corcoran, P. A. (1961). A new phenotype (McLeod) in the Kell blood-group system. Vox Sang, 6, 555–60CrossRef Google Scholar PubMed

Asano, K., Osawa, Y., Yanagisawa, N., Takahashi, Y. & Oshima, M. (1985). Erythrocyte abnormalities in patients with amyotrophic chorea with acanthocytosis. Part II. Abnormalities of membrane proteins. J. Neurol. Sci., 68, 161–73CrossRef Google Scholar

Bassen, F. A. & Kornzweig, A. L. (1950). Malformation of the erythrocytes in a case of atypical retinitis pigmentosa. Blood, 5, 381–7Google Scholar

Bertelson, C. J., Pogo, A. O., Chaudhuri, A.et al. (1988). Localization of the McLeod locus (XK) within Xp21 by deletion analysis. Am. J. Hum. Genet., 42(5), 703–11Google Scholar PubMed

Bird, T. B., Cederbaum, S., Valpey, R. W. & Stahl, W. L. (1978). Familial degeneration of the basal ganglia with acanthocytosis: a clinical, neuropathological and neurochemical study. Ann. Neurol., 3, 253–8CrossRef Google Scholar PubMed

Bishara, S., Merin, S., Cooper, M., Azizi, E., Delpre, G. & Deckelbaum, R. J. (1982). Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinaemia. Br. J. Ophthalmol., 66(12), 767–70CrossRef Google Scholar

Bohlega, S., Al-Jishi, A., Dobson-Stone, C.et al. (2003). Chorea-acanthocytosis: clinical and genetic findings in three families from the Arabian peninsula. Mov. Disord., 18(4), 403–7CrossRef Google Scholar PubMed

Bostantjopoulou, S., Katsarou, Z., Kazis, A. & Vadikolia, C. (2000). Neuroacanthocytosis presenting as parkinsonism. Mov. Disord., 15, 1271–23.0.CO;2-T>CrossRef Google Scholar PubMed

Branch, D. R., Sy Siok Hian, A. L. & Petz, L. D. (1985). Unmasking of Kx antigen by reduction of disulphide bonds on normal and McLeod red cells. Br. J. Haematol., 59(3), 505–12CrossRef Google Scholar PubMed

Brin, M. F. (1993). Acanthocytosis. In Handbook of Clinical Neurology, Vol. 19(63), ed. C. G. Goetz, C. M. Tanner & M. J. Aminoff, Amsterdam: Elsevier, pp. 271–99

Brooks, D. J., Ibanez, V., Playford, E. D.et al. (1991). Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: A positron emssion tomographic study. Ann. Neurol., 30, 166–71CrossRef Google Scholar PubMed

Ching, K. H. L., Westaway, S. K., Gitschier, J., , Higgins, J. J. & Hayflick, S. J. (2002). HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration. Neurology, 58, 1673–4CrossRef Google Scholar PubMed

Clark, M. R., Aminoff, M. J., Chiu, D. T., Kuypers, F. A. & Friend, D. S. (1989). Red cell deformability and lipid composition in two forms of acanthocytosis: enrichment of acanthocytic populations by density gradient centrifugation. J. Lab. Clin. Med., 113(4), 469–81Google Scholar PubMed

Carter, N. D., Morgan, J. E., Monaco, A. P., Schwartz, M. S. & Jeffery, S. (1990). Dystrophin expression and genotypic analysis of two cases of benign X linked myopathy (McLeod's syndrome). J. Med. Genet., 27(6), 345–7CrossRef Google Scholar

Cooper, R. A., Durocher, J. R. & Leslie, M. H. (1977). Decreased fluidity of red cell membrane lipids in abetalipoproteinemia. J. Clin. Invest., 60(1), 115–21CrossRef Google Scholar PubMed

Critchley, E. M. R., Clark, D. B. & Wikler, A. (1968). Acanthocytosis and neurological disorder without abetalipoproteinemia. Arch. Neurol., 18, 134–40CrossRef Google Scholar

Danek, A., Rubio, J. P., Rampoldi, L.et al. (2001). McLeod neuroacanthocytosis: genotype and phenotype. Ann. Neurol., 50(6), 755–64CrossRef Google Scholar PubMed

Danek, A., Witt, T. N., Stockmann, H. B., Weiss, B. J., Schotland, D. L. & Fischbeck, K. H. (1990). Normal dystrophin in McLeod myopathy. Ann. Neurol., 28(5), 720–2CrossRef Google Scholar

Danek, A., Uttner, U., Vogl, T., Tatsch, K. & Witt, T. N. (1994). Cerebral involvement in McLeod syndrome. Neurology, 44, 117–20CrossRef Google Scholar PubMed

Danek, A., Tierney, M., Sheesley, L. & Grafman, J. (2001). Cognitive findings in patients with chorea-acanthocytosis. Mov. Disord., 16(Suppl 1), S30Google Scholar

Delecluse, F., Deleval, J., Gerard, J. M., Michotte, A. & Zegers de Beyl, D. (1991). Frontal impairment and hypoperfusion in neuroacanthocytosis. Arch. Neurol., 48(2), 232–4CrossRef Google Scholar PubMed

Dexter, D. T., Brooks, D. J., Harding, A. E.et al. (1994). Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studies. Ann. Neurol., 35(3), 298–303CrossRef Google Scholar PubMed

Yebenes, J. G., Brin, M. F., Mena, M. A.et al. (1988). Neurochemical findings in Neuroacanthocytosis. Mov. Disord., 3, 300–12CrossRef Google Scholar PubMed

Dobson-S tone, C., Danek, C., Rampoldi, L.et al. (2002). Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur. J. Hum. Genet., 10(11), 773–81CrossRef Google Scholar

Dotti, M. T., Battisti, C., Malandrini, A.et al. (2000). McLeod syndrome and neuroacanthocytosis with a novel mutation in the XK gene. Mov. Disord., 15(6), 1282–43.0.CO;2-2>CrossRef Google Scholar PubMed

Dubinsky, R. M., Hallett, M., Levey, R. & Di Chiro, G. (1989). Regional brain glucose metabolism in neuroacanthocytosis. Neurology, 39(9), 1253–5CrossRef Google Scholar PubMed

Estes, J. W., Morley, T. J., Levine, I. M. & Emerson, C. P. (1967). A new hereditary acanthocytosis syndrome. Am. J. Med., 42, 868–88CrossRef Google Scholar PubMed

Eto, Y. & Kitagawa, T. (1970). Wolman's disease with hypolipoproteinemia and acanthocytosis: clinical and biochemical observations. J. Pediat., 77, 862–7CrossRef Google Scholar

Farese, R. V., Garg, A., , Peirotti, V. R., Veega, G. L. & Young, S. G. (1992). A truncated species of apolipoprotein B, B-83, associated with hypolipoproteinemia. J. Lipid Res., 33, 569–77Google Scholar

Feinberg, T. E., Cianci, C. D., Morrow, J. S.et al. (1991). Koroshetz, W. J.Diagnostic test for choreoacanthocytosis. Neurology, 41, 1000–6CrossRef Google Scholar

Hardie, R. J., Pullon, H. W., Harding, A. E.et al. (1991). Neuroacanthocytosis: a clinical, hematological and pathological study of 19 cases. Brain, 114, 13–49Google Scholar

Harding, A. E. (1987). Vitamin E and the nervous system. Crit. Rev. Neurobiol., 3, 89–103Google Scholar

Hayflick, S. J. (2003). Pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome). J. Neurol. Sci., 207, 106–7CrossRef Google Scholar

Higgins, J. J., Patterson, M. C., Papadopoulos, N. M., Brady, R. O., Pentchev, P. G. & Barton, N. W. (1992). Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa and pallidal degeneration (HARP syndrome). Neurology, 42, 194–8CrossRef Google Scholar

Ho, M. F., Monaco, A. P., Blonden, L. A.et al. (1992). Fine mapping of the McLeod locus (XK) to a 150–380-kb region in Xp21. Am. J. Hum. Genet., 50(2), 317–30Google Scholar PubMed

Ho, M., Chelly, J., Carter, N., Danek, A., Crocker, P. & Monaco, A. P. (1994). Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell, 77(6), 869–80CrossRef Google Scholar PubMed

Ho, M. F., Chalmers, R. M., Davis, M. B., Harding, A. E. & Monaco, A. P. (1996). A novel point mutation in the McLeod syndrome gene in neuroacanthocytosis. Ann. Neurol., 39(5), 672–5CrossRef Google Scholar PubMed

Holmes, S. E., O'Hearn, E., Rosenblatt, A.et al. (2001). A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat. Genet., 29(4), 377–8CrossRef Google Scholar PubMed

Iida, H., Takashima, Y., Maeda, S.et al. (1984). Alterations in erythrocyte membrane lipids in abetalipoproteinemia: phospholipid and fatty acyl composition. Biochem. Med., 32(1), 79–87CrossRef Google Scholar PubMed

Jamil, H., Chu, C. H., Dickson, J. K. Jr. et al. (1998). Evidence that microsomal triglyceride transfer protein is limiting in the production of apolipoprotein B-containing lipoproteins in hepatic cells. J. Lipid Res., 39(7), 1448–54Google Scholar PubMed

Jung, H. H., Hergersberg, M., Kneifel, S.et al. (2001). McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings. Ann. Neurol., 49(3), 384–92CrossRef Google Scholar PubMed

Jung, H. H., Hergersberg, M., Vogt, M.et al. (2003). Kollias, S. S., Russo, D. & Frey, B. M. (2003). McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement. Transfusion, 43, 923–8CrossRef Google Scholar PubMed

Kartsounis, L. D. & Hardie, R. J. (1996). The pattern of cognitive impairments in neuroacanthocytosis. Arch. Neurol., 53, 77–80CrossRef Google Scholar PubMed

Kayden, H. J. & Traber, M. G. (1993). Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J. Lipid Res., 43, 343–58Google Scholar

Kazis, A., Kimiskidis, V., Georgiadis, G. & Voloudaki, E. (1995). Neuroacanthocytosis presenting with epilepsy. J. Neurol., 242, 415–17CrossRef Google Scholar PubMed

Khamlichi, S., Bailly, P., Blanchard, D., Goossens, D., Cartron, J. P. & Bertrand, O. (1995). Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients. Eur. J. Biochem., 228(3), 931–4CrossRef Google Scholar PubMed

Köhler, B. (1989). Hallervorden–Spatz syndrome with acanthocytosis. Monatsschr. Kinderheilkund., 137, 616–19Google Scholar PubMed

Lee, S., Lin, M., Mele, A.et al. (1999). Proteolytic processing of big endothelin-3 by the kell blood group protein. Blood, 94(4), 1440–50Google Scholar PubMed

Lerche, H., Storch, A., Pekrun, A.et al. (2000). A novel form of autosomal dominant neuroacanthocytosis with exertion-induced paroxysmal dyskinesias. J. Neurol., 247(Suppl 1), S43Google Scholar

Levine, I. M., Estes, J. W. & Looney, J. M. (1968). Hereditary neurological disease with acanthocytosis. Arch. Neurol., 19, 403–9CrossRef Google Scholar PubMed

Liang, J., & Ginsberg, H. N. (2001). Microsomal triglyceride transfer protein binding and lipid transfer activities are independent of each other, but both are required for secretion of apolipoprotein B lipoproteins from liver cells. J. Biol. Chem., 276(30), 28606–12CrossRef Google Scholar

Linton, M. F., Farese, R. V. & Young, S. G. (1993). Familial hypobetalipoproteinemia. J. Lipid Res., 34, 521–41Google Scholar PubMed

Luckenbach, M. W., Green, W. R., Miller, N. R., Moser, H. W., Clark, A. W. & Tennekoon, G. (1983). Ocular clinicopathologic correlation of Hallervorden–Spatz syndrome with acanthocytosis and pigmentary retinopathy. Am. J. Ophthalmol., 95, 369–82CrossRef Google Scholar PubMed

Malandrini, A., Fabrizi, G. M., Palmeri, S. (1993). Choreo-acanthocytosis like phenotype without acanthocytes: clinicopathological case report. A contribution to the knowledge of the functional pathology of the caudate nucleus. Acta Neuropathol. (Berl.), 86(6), 651–8CrossRef Google Scholar PubMed

Malandrini, A., Fabrizi, G. M., Truschi, F.et al. (1994). Atypical McLeod syndrome manifested as X-linked chorea-acanthocytosis, neuromyopathy and dilated cardiomyopathy: report of a family. J. Neurol. Sci., 124(1), 89–94CrossRef Google Scholar PubMed

Malandrini, A., Cesaretti, S., Mulinari, M.et al. (1996). Acanthocytosis, retinitis pigmentosa, pallidal degeneration. Report of two cases without serum lipid abnormalities. J. Neurol. Sci., 140, 129–31CrossRef Google Scholar PubMed

Marson, A. M., Bucciantini, E., Gentile, E. & Geda, C. (2003). Neuroacanthocytosis: clinical, radiological, and neurophysiological findings in an Italian family. Neurol. Sci., 24(3), 188–9CrossRef Google Scholar

Morrow, J. & Andersen, R. (1986). Shaping the too fluid bilayer. Lab. Invest., 54, 237–9Google Scholar PubMed

Muller, D. P., Lloyd, J. K. & Wolff, O. H. (1985). The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption. J. Inherit. Metab. Dis., 8(Suppl 1), 88–92CrossRef Google Scholar PubMed

Nakayama, K. (1997). Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J., 327, 625–35CrossRef Google Scholar PubMed

Nelson, J. S., Fitch, C. D., Fischer, V. W., Broun, G. O. Jr. & Chou, A. C. (1981). Progressive neuropathologic lesions in vitamin E-deficient rhesus monkeys. J. Neuropathol. Exp. Neurol., 40(2), 166–86CrossRef Google Scholar PubMed

O'Brien, C. F., Schwartz, H. & Kurlan, R. (1990). Neuroacanthocytosis without acanthocytes. Mov. Disord., 5(Suppl 1), 98Google Scholar

Ohashi, K., Ishibashi, S., Osuga, J.et al. (2000). Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia. J. Lipid Res., 41(8), 1199–204Google Scholar PubMed

Okamoto, K., Ito, J., Furusawa, T.et al. (1997). CT and MR findings of neuroacanthocytosis. J. Comput. Assist. Tomogr., 21(2), 221–2CrossRef Google Scholar

Orrell, R. W., Amrolia, P. J., Heald, A.et al. (1995). Acanthocytosis, retinitis pigmentosa, and pallidal degeneration: a report of three cases, including the second reported case with hypoprebetalipoproteinemia (HARP syndrome). Neurology, 45, 487–92CrossRef Google Scholar

Oshima, M., Osawa, Y., Asano, K. & Saito, T. (1985). Erythrocyte membrane abnormalities in patients with amyotrophic chorea with acanthocytosis. I. Spin labeling studies and lipid analyses. J. Neurol. Sci., 68, 147–60CrossRef Google Scholar PubMed

Rampoldi, L., Dobson-Stone, C., Rubio, J. P.et al. (2001). A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat. Genet., 28(2), 119–20CrossRef Google Scholar PubMed

Raymond, C. K., Howald-Stevenson, I., Vater, C. A. & Stevens, T. H. (1992). Morphological classification of the yeast vacuolar protein sorting mutants: evidence for a prevacuolar compartment in class E vps mutants. Mol. Biol. Cel., 3(12), 1389–402CrossRef Google Scholar PubMed

Rinne, J. O., Daniel, S. E., Scaravilli, F., Pires, M., , Harding, A. E. & Marsden, C. D. (1994). The neuropathological features of neuroacanthocytosis. Mov. Disord., 9, 297–304CrossRef Google Scholar PubMed

Ross, R. S., Gregg, R. E., Law, S. W.et al. (1988). Homozygous hypobetalipoproteinemia: a disease distinct from abetalipoproteinemia at the molecular level. J. Clin. Invest., 81, 590–5CrossRef Google Scholar PubMed

Roth, A. M., Helper, R. S., Mukoyama, M., Cancilla, P. A. & Foos, R. Y. (1971). Pigmentary retinal dystrophy in Hallervorden–Spatz disease. Clinicopathological report of a case. Surv. Ophthalmol., 16, 24–35Google Scholar

Rubio, J. P., Danek, A., Stone, C.et al. (1997). Chorea-acanthocytosis: genetic linkage to chromosome 9q21. Am. J. Hum. Genet., 61, 899–908CrossRef Google Scholar PubMed

Russo, D. C., Lee, S., Reid, M. & Redman, C. M. (1994). Topology of Kell blood group protein and the expression of multiple antigens by transfected cells. Blood, 84(10), 3518–23Google Scholar PubMed

Russo, D. C., Lee, S. & Redman, C. M. (1999). Intracellular assembly of Kell and XK blood group proteins. Biochim. Biophys. Act., 1461(1), 10–18CrossRef Google Scholar PubMed

Russo, D., Wu, X., Redman, C. M. & Lee, S. (2000). Expression of Kell blood group protein in nonerythroid tissues. Blood, 96(1), 340–6Google Scholar PubMed

Saiki, S., Sakai, K., Kitagawa, Y., Saiki, M., Kataoka, S. & Hirose, G. (2003). Mutation in the CHAC gene in a family of autosomal dominant chorea-acanthocytosis. Neurology, 61, 1614–6CrossRef Google Scholar

Sakai, T., Antoku, Y., Iwashita, H., Goto, I., Nagamatsu, K. & Shii, H. (1991). Chorea-acanthocytosis: abnormal composition of covalently bound fatty acids of erythrocyte membrane proteins. Ann. Neurol., 29, 664–9CrossRef Google Scholar PubMed

Sharp, D., Blinderman, L., Combs, K. A.et al. (1993). Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature, 365, 65–9CrossRef Google Scholar PubMed

Shoulders, C. C., Brett, D. J., Bayliss, J. D.et al. (1993). Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum. Mol. Genet., 2, 2109–16CrossRef Google Scholar PubMed

Sorrentino, G., Renzo, A., Miniello, S., Nori, O. & Bonavita, V. (1999). Late appearance of acanthocytes during the course of chorea-acanthocytosis. J. Neurol. Sci., 163, 175–8CrossRef Google Scholar PubMed

Spencer, S. E., Walker, F. O. & Moore, S. A. (1987). Chorea-amyotrophy with chronic hemolytic anemia. A variant of chorea-amyotrophy with acanthocytosis. Neurology, 37, 645–9CrossRef Google Scholar PubMed

Spitz, M. C., Jankovic, J., & Killian, J. M. (1985). Familian tic disorder, parkinsonism, motor neuron disease and acanthocytosis: a new syndrome. Neurology, 35, 366–70CrossRef Google Scholar

Stanfield, G. M. & Horvitz, H. R. (2000). The ced-8 gene controls the timing of programmed cell deaths in C. elegans. Mol. Cel., 5(3), 423–3CrossRef Google Scholar PubMed

Stege, J. T., Laub, M. T. & Loomis, W. F. (1999). tip genes act in parallel pathways of early Dictyostelium development. Dev. Genet., 25(1), 64–773.0.CO;2-1>CrossRef Google Scholar PubMed

Stevenson, V. L. & Hardie, R. J. (2001). Acanthocytosis and neurological disorders. J. Neurol., 248, 87–94CrossRef Google Scholar PubMed

Storch, A., Kornhass, M. & Schwarz, J. (2004). Testing for acanthocytosis: a prospective reader-blinded study in movement disorder patients. J. Neurol., in press

Storch, A., , Ludolph, A. C. & Schwarz, J. (1998). The importance of standardized blood investigations for acanthocytosis in patients with unusual movement disorders. Neurology, 50(Suppl 4), A252Google Scholar

Storch, A. & Schwarz, J. Diagnostic test for neuroacanthocytosis: quantitative measurement of red cell morphology. In Neuroacanthocytosis Syndromes, ed. A. Danek, New York: Kluwer Academic Press, pp. 71–8

Swisher, C. N., Menkes, J. H., Cancilla, P. A. & Dodge, P. R. (1972). Co-existence of Hallervorden-Spatz disease with acanthocytosis. Trans. Am. Neurol. Assoc., 97, 212–16Google Scholar

Tanaka, M., Hirai, S., Kondo, S.et al. (1998). Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis: a combined PET and MRI study. Mov. Disord., 13(1), 100–7CrossRef Google Scholar PubMed

Terada, N., Fujii, Y., Ueda, H.et al. (1999). Ultrastructural changes of erythrocyte membrane skeletons in chorea-acanthocytosis and McLeod syndrome revealed by the quick-freezing and deep-etching method. Acta Haematol., 101(1), 25–31CrossRef Google Scholar PubMed

Ueno, S., Maruki, Y., Nakamura, M.et al. (2001). The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis. Nat. Genet., 28(2), 121–2CrossRef Google Scholar PubMed

Ueno, E., Oguchi, K. & Yanagisawa, N. (1982). Morphological abnormalities of erythrocyte membrane in the hereditary neurological disease with chorea, areflexia and acanthocytosis. J. Neurol. Sci., 56(1), 89–97CrossRef Google Scholar PubMed

Walker, R. H., Morgello, S., Davidoff-Feldman, B.et al. (2002). Autosomal dominant chorea-acanthocytosis with polyglutamine-containing neuronal inclusions. Neurology, 58(7), 1031–7CrossRef Google Scholar PubMed

Walker, R. H., Davidoff-Feldman, B., , Rudnicki, D., , Holmes, S. E. & Margolis, R. L. (2003). Huntington's disease-like type 2 with and without acanthocytosis. Neurology, 60(Suppl 1), A287Google Scholar

Welty, F. K., Lahoz, C., , Tucker, K. L., Ordovas, J. M., Wilson, P. W. & Schaefer, E. J. (1998). Frequency of ApoB and ApoE gene mutations as causes of hypobetalipoproteinemia in the Framingham offspring population. Arterioscler. Thromb. Vasc. Biol., 18(11), 1745–51CrossRef Google Scholar PubMed

Wetterau, J. R., Aggerbeck, L. P., Bouma, M. E.et al. (1992). Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science, 258, 999–1001CrossRef Google Scholar PubMed

Wimer, B. M., Marsh, W. L., Taswell, H. F. & Galey, W. R. (1977). Haematological changes associated with the McLeod phenotype of the Kell blood group system. Br. J. Haematol., 36(2), 219–24CrossRef Google Scholar PubMed

Witt, T. N., Danek, A., , Reiter, M., , Heim, M. U., Dirschinger, J., & Olsen, E. G. (1992). McLeod syndrome: a distinct form of neuroacanthocytosis. Report of two cases and literature review with emphasis on neuromuscular manifestations. J. Neurol., 239(6), 302–6CrossRef Google Scholar PubMed

Wolman, M. (1995). Wolman disease and its treatment. Clin. Pediatr., 34(4), 207–12CrossRef Google Scholar PubMed

Wu, J., Kim, J., Li, Q.et al. (1999). Known mutations of apoB account for only a small minority of hypobetalipoproteinemia. J. Lipid Res., 40(5), 955–9Google Scholar

Young, S. G., Berties, S. J., Curtiss, L. K. & Witztum, J. L. (1987). Characterisation of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia. J. Clin. Invest., 79, 1831–41CrossRef Google Scholar

Young, S. G., Narthey, S. T. & McCarthy, B. J. (1988). Low plasma cholesterol levels caused by a short deletion in the apolipoprotein B gene. Science, 241, 591–3CrossRef Google Scholar

Yuan, B., Neuman, R., Duan, S. H.et al. (2000). Linkage of a gene for familial hypobetalipoproteinemia to chromosome 3p21.1–22. Am. J. Hum. Genet., 66(5), 1699–704CrossRef Google Scholar PubMed

Zhou, B., Westaway, S. K., Levinson, B., , Johnson, M. A., Gitschier, J. & Hayflick, S. J. (2001). A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat. Genet., 28, 345–9CrossRef Google Scholar

Book contents

59 - Neuroacanthocytosis

Summary

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive